ALLOX
ALLOX is developing a drug discovery platform that combines high-throughput genetics, experimental biology and artificial intelligence to identify previously unexplored opportunities for developing small-molecule therapeutics.
ALLOX has raised €9.4M across 1 funding round from 4 investors, most recently a Seed round in Oct 2026. Based in Barcelona, Spain; active in Healthtech. Data as of 29 Oct 2026.
Barcelona, Spainwww.allox.bio ↗
Total raised
€9.4M
€9,433,962
Funding rounds
1
Investors
4
distinct backers
Active since
2026-10
latest 2026-10
Funding by year
EUR raised per year · 2026 YTDALLOX — funding by year — interactive chart.
Data table
| ALLOX — funding by year | |
|---|---|
| 2026 | €9.4M |
Signals
High confidenceRaise-next likelihood14
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-29 | Seed | €9.4M | Asabys Partners,CDTI,Institut Català de Finances (ICF),SICC Innvierte fund | View deal → |
Related news
Similar companies
same sector, similar size- iPremom€15MSpain · Healthtech
- Gate2Brain€9.5MSpain · Healthtech
- Tetraneuron€9.9MSpain · Healthtech
- Accure Therapeutics€9.1MSpain · Healthtech
- Onalabs€12MSpain · Healthtech
- Irisbond€8.4MSpain · Healthtech
Global coverage: FundingData